Medicxi Ventures Management (Jersey) Ltd
Follow13F filer, CIK 1715579, ST. HELIER, Jersey
Medicxi Ventures Management (Jersey) Ltd reported $437,696,267 across 5 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-04-11.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-003449
- Period
- 2025-03-31
- Reported value
- $438M
- Holdings
- 5
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Holdings, Q1 2025
Share positions as resolved from 13F-HR 0000950123-25-003449, largest first. % of portfolio is the value over $437,696,267, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| CNTACENTESSA PHARMACEUTICALS PLC | 19,963,157 | $287M | 65.59% | 0 | Timeline | ||
| NAMSNEWAMSTERDAM PHARMA COMPANY | 2,869,565 | $58.7M | 13.42% | 0 | Timeline | ||
| PHATPHATHOM PHARMACEUTICALS INC | 7,464,572 | $46.8M | 10.69% | 0 | Timeline | ||
| RAPT THERAPEUTICS INCRAPT THERAPEUTICS INC | 22,352,000 | $27.3M | 6.23% | 0 | |||
| AURAAURA BIOSCIENCES INC | 3,039,892 | $17.8M | 4.07% | 0 | Timeline |
How Q1 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-25-003449 | base | 2025-04-11 | acceptance time not in the bulk data set |